Generic Healthcare Business

Generic Healthcare Business

As a leading generic medicines manufacturer in India, Ind-Swift Group is committed to delivering affordable, high-quality formulations that meet global regulatory standards. Our WHO-GMP certified plants in Derabassi and Samba ensure compliance, consistency, and global acceptance.

We offer a wide range of generic pharmaceutical products across key therapeutic categories including cardiology, anti-infectives, CNS, gastroenterology, anti-diabetics, and more. These are manufactured using stringent quality control protocols and exported to Asia, Africa, LATAM, CIS, and semi-regulated markets.

Our generic business is backed by a robust supply chain, regulatory support, and a customer-focused approach, helping us maintain a strong international presence. Whether you're a distributor, healthcare provider, or partner, Ind-Swift stands as your reliable source for safe, effective, and affordable generics.

Explore our product range and discover how Ind-Swift is shaping a healthier world through generic medicines.

Strategic Strengths of the Generic Business Division

Global Regulatory Compliance

Our manufacturing facilities are WHO-GMP certified and adhere to international standards, ensuring that our generic products meet the quality and safety requirements of global health authorities.

Diverse Therapeutic Portfolio

We offer a wide range of generic formulations across therapeutic areas including anti-infectives, cardiology, diabetology, CNS, gastroenterology, and more—designed to address high-burden medical conditions at scale.

Strong Export Capabilities

Our generics are priced to enable broad access while maintaining therapeutic efficacy, safety, and consistency—supporting national and international public health goals.

Flexible Manufacturing & Supply Chain

We provide scalable production backed by responsive supply chain systems to fulfill bulk requirements, private label partnerships, and long-term distribution contracts efficiently.